Evidence map›Paper›PMID 40299336›Full record

ArticleBiomedicines2025

Synthesis and Evaluation of Isosteviol Derivatives: Promising Anticancer Therapies for Colon Cancer.

Yecang Chen, Feifei Zhu, Yuxin Ding, Lin Xing, Enxiao Wang, Yixiang Fang, Ruilong Sheng, Qidong Tu, Ruihua Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yecang ChenDivision of Biomedical Engineering, James Watt School of Engineering, University of Glasgow, Glasgow G12 8LT, UK.
Feifei ZhuCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Yuxin DingCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Lin XingCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Enxiao WangCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Yixiang FangCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Ruilong ShengCQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9000-390 Funchal, Portugal.ORCID 0000-0002-3303-3832
Qidong TuJiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China.
Ruihua GuoCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.ORCID 0000-0001-8414-886X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancercolon cancerisosteviolmolecular dockingstructure-activity relationshipsTP53

Identifiers

PMID40299336
PMCPMC12024579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.